Who
Chris Freeman
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Guardant Health.
In numbers
- Trades disclosed
- 203
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $30.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Aug 2021
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,929 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,668 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,527 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,292 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $549K3,143 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,929 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,668 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,527 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,292 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $3.9M35,412 at $110.49 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $800K28,193 at $28.37 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $580K3,463 at $167.38 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —35,412 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —28,193 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.2M7,365 at $168.79 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $6.0M35,364 at $169.63 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $3.0M17,413 at $170.24 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —35,412 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —28,193 at $0.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $3.9M35,412 at $110.49 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Contrasting BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH)GH · tickerreport.com · 21 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026
0 headlines in the last 90 days name Chris Freeman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.